# CARBETOCIN VERSUS RECTAL MISOPROSTOL FOR MANAGEMENT OF THIRD STAGE OF LABOR IN WOMEN AT LOW RISK OF POSTPARTUM HEMORRHAGE

> **NCT03556852** · PHASE4 · COMPLETED · sponsor: **Cairo University** · enrollment: 150 (actual)

## Conditions studied

- Postpartum Hemorrhage

## Interventions

- **DRUG:** Carbetocin
- **DRUG:** Misoprostol

## Key facts

- **NCT ID:** NCT03556852
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-02
- **Primary completion:** 2019-05-24
- **Final completion:** 2019-05-30
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2019-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03556852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03556852, "CARBETOCIN VERSUS RECTAL MISOPROSTOL FOR MANAGEMENT OF THIRD STAGE OF LABOR IN WOMEN AT LOW RISK OF POSTPARTUM HEMORRHAGE". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03556852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*